Literature DB >> 28342665

Recombinant Newcastle disease virus expressing the infectious bronchitis virus S1 gene protects chickens against Newcastle disease virus and infectious bronchitis virus challenge.

Ran Zhao1, Junfeng Sun2, Tianming Qi2, Wen Zhao2, Zongxi Han2, Xiaopu Yang3, Shengwang Liu4.   

Abstract

The recombinant LaSota strain expressing a chimeric IBV S1 gene (rLaSota-S1) was constructed with the S1 gene of the LX4 type IBV ck/CH/LDL/091022. The expression of the S1 protein was detected by an indirect immunofluorescence assay and Western blotting. The rLaSota-S1 strain was slightly attenuated, and its growth dynamics were similar to that of the parental LaSota strain. Vaccination of specific pathogen-free chickens with the rLaSota-S1 strain induced NDV hemagglutination inhibition antibodies, and it protected chickens from challenge with virulent NDV. In addition, vaccination with the rLaSota-S1 strain induced IBV-specific IgG antibodies and cellular immunity; however, a single vaccination provided partial protection with reduced virus shedding. Better protection efficiency was observed after a booster vaccination, which resulted in higher antibody titers, significantly fewer disease symptoms, and reduced virus replication and shedding. Our results suggest that the rLaSota-S1 strain is a bivalent vaccine candidate against both NDV and IBV.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bivalent vaccine candidate; Infectious bronchitis virus; LX4 genotype; Newcastle disease virus; Recombinant LaSota strain

Mesh:

Substances:

Year:  2017        PMID: 28342665     DOI: 10.1016/j.vaccine.2017.03.045

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Surveillance of Class I Newcastle Disease Virus at Live Bird Markets in China and Identification of Variants with Increased Virulence and Replication Capacity.

Authors:  Junfeng Sun; Hui Ai; Linna Chen; Le Li; Qiankai Shi; Tianyi Liu; Ran Zhao; Chunwei Zhang; Zongxi Han; Shengwang Liu
Journal:  J Virol       Date:  2022-05-05       Impact factor: 6.549

2.  Construction and immune protection evaluation of recombinant virus expressing Newcastle disease virus F protein by the largest intergenic region of fowlpox virus NX10.

Authors:  Yan Zhao; Zongxi Han; Xiaocai Zhang; Xuemei Zhang; Junfeng Sun; Deying Ma; Shengwang Liu
Journal:  Virus Genes       Date:  2020-10-03       Impact factor: 2.332

Review 3.  Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology.

Authors:  Muhammad Bashir Bello; Khatijah Yusoff; Aini Ideris; Mohd Hair-Bejo; Abdurrahman Hassan Jibril; Ben P H Peeters; Abdul Rahman Omar
Journal:  Viruses       Date:  2020-04-16       Impact factor: 5.048

4.  Comparative Protective Efficacies of Novel Avian Paramyxovirus-Vectored Vaccines against Virulent Infectious Bronchitis Virus in Chickens.

Authors:  Edris Shirvani; Siba K Samal
Journal:  Viruses       Date:  2020-06-28       Impact factor: 5.048

5.  A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus.

Authors:  Jianping Li; Zeinab H Helal; Christopher P Karch; Neha Mishra; Theodore Girshick; Antonio Garmendia; Peter Burkhard; Mazhar I Khan
Journal:  PLoS One       Date:  2018-09-14       Impact factor: 3.240

6.  A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV.

Authors:  Edris Shirvani; Anandan Paldurai; Vinoth K Manoharan; Berin P Varghese; Siba K Samal
Journal:  Sci Rep       Date:  2018-08-10       Impact factor: 4.379

7.  Construction and Immunogenicity of Novel Chimeric Virus-Like Particles Bearing Antigens of Infectious Bronchitis Virus and Newcastle Disease Virus.

Authors:  Xuan Wu; Xiwen Zhai; Yan Lai; Lei Zuo; Yu Zhang; Xueran Mei; Rong Xiang; Zhuangzhuang Kang; Long Zhou; Hongning Wang
Journal:  Viruses       Date:  2019-03-13       Impact factor: 5.048

8.  Identification of Amino Acids within Nonstructural Proteins 10 and 14 of the Avian Coronavirus Infectious Bronchitis Virus That Result in Attenuation In Vivo and In Ovo.

Authors:  Sarah Keep; Phoebe Stevenson-Leggett; Giulia Dowgier; Holly Everest; Graham Freimanis; Michael Oade; John A Hammond; Maria Armesto; Rut Vila; Tura Bru; Harm Geerligs; Paul Britton; Erica Bickerton
Journal:  J Virol       Date:  2022-01-19       Impact factor: 5.103

9.  Limited Cross-Protection against Infectious Bronchitis Provided by Recombinant Infectious Bronchitis Viruses Expressing Heterologous Spike Glycoproteins.

Authors:  Sarah Keep; Samantha Sives; Phoebe Stevenson-Leggett; Paul Britton; Lonneke Vervelde; Erica Bickerton
Journal:  Vaccines (Basel)       Date:  2020-06-22

10.  Recombinant Infectious Bronchitis Viruses Expressing Chimeric Spike Glycoproteins Induce Partial Protective Immunity against Homologous Challenge despite Limited Replication In Vivo.

Authors:  Erica Bickerton; Lonneke Vervelde; Samantha Ellis; Sarah Keep; Paul Britton; Sjaak de Wit
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.